- ABOUT US
- SERVICES
- FACILITY
- CONDITIONS
- Age-Related Macular Degeneration
- Birdshot Retinochoroidopathy
- Branch Retinal Artery Occlusion
- Branch Retinal Vein Occlusion
- Central Retinal Artery Occlusion
- Central Retinal Vein Occlusion
- Central Serious Retinopathy
- Coats' Disease
- Cystoid Macular Edema
- Cytomegalovirus Retinitis
- Detached and Torn Retina
- Diabetic Eye Disease
- Diabetic Retinopathy
- Flashes & Floaters
- Lattice Degeneration
- Macular Dystrophy
- Macular Edema
- Macular Hole
- Nonproliferative Diabetic Retinopathy
- Ocular Histoplasmosis Syndrome
- Proliferative Diabetic Retinopathy
- Rentinitis Pigmentosa
- Rentinoblastoma
- Rentinopathy of Prematurity
- Rentinoschsis
- Stargardt's Disease
- Toxoplasmosis
- Uveitis
- Vitrectomy Surgery
- Vitreous Hemorrhage
- PATIENT CARE
- CONTACT US
Press Room
Business Leaders On The Move In Hawaii
Compiled by Alana Folen Wednesday - January 13, 2010
Dr. Gene Ng has joined Retina Institute of Hawaii’s team of ophthalmologists and surgeons. He has a strong background and interest in the development of new drugs and was a member of the management team of Eyetech, where he contributed to the development and launch of Macugen, the first anti-VEGF treatment for wet macular degeneration.
